席尔德纳菲尔对丸激素诱导的前列腺缩和尿膀部肌肉放松的影响
Qasim A El-Dwairi1, Karem H Alzoubi2, Rania Mahafdeh3
1Department of Anatomy, Faculty of Medicine, Jordan University of Science & Technology, Irbid 22110, Jordan.
Toxicology reports
|July 18, 2025
概括
在良性前列腺增生症 (BPH) 的子模型中,西尔德纳菲尔显著降低了前列腺体重和放松了膀部肌肉. 这表明西尔代纳菲尔可以治疗勃起功能障碍和BPH尿路症状.
科学领域:
- 药理学 药理学是指药理学的学科.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 安德罗学与人类学
背景情况:
- 固酶-5 (PDE5) 受体在前列腺组织中表达.
- 良性前列腺增生 (BPH) 是老年男性的常见疾病.
- 子中丸激素诱导的BPH作为一个相关的动物模型.
研究的目的:
- 在子模型中研究西尔德纳菲尔酸盐的疗效,用于丸激素诱导的良性前列腺增生 (BPH).
- 评估西尔代纳菲尔对前列腺体重和膀部肌肉放松的影响.
主要方法:
- 良性前列腺增生症在子中被诱导使用氨酸.
- 子每天接受西尔代纳菲尔治疗 (5毫克/公斤/天) 持续8周.
- 评估了前列腺体重,膀部肌肉放松和组织病理变化.
主要成果:
- 在BPH子中,西尔德纳菲尔治疗减少了65.34%的前列腺体重.
- 席尔德纳菲尔在预先收缩的膀部肌肉条中诱导了显著的光滑肌肉放松 (32.8%的减少).
- 组织病理学分析显示,西尔代纳菲尔逆转了激素诱导的过度缩和超塑性变化.
结论:
- 在BPH模型中,西尔德纳菲尔在减少前列腺体重和改善膀部肌肉功能方面表现出有效性.
- 西尔德纳菲尔可能为患有勃起功能障碍和BPH相关的尿路症状的患者提供双重治疗益处.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
254
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
254
Antihypertensive Drugs: Vasodilators
645
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
645
Male Sexual Response: Erection & Ejaculation
5.0K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
5.0K
Nitric Oxide Signaling Pathway
5.2K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.2K
Disorders of the Male Reproductive System
581
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
581
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
983
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
983


